Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03250832
Title Study of TSR-033 With an Anti-PD-1
Acronym CITRINO
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90095 United States Details
GSK Investigational Site Whittier California 90603 United States Details
GSK Investigational Site Sarasota Florida 34232 United States Details
GSK Investigational Site Tampa Florida 33612 United States Details
GSK Investigational Site Boston Massachusetts 02115 United States Details
GSK Investigational Site Cleveland Ohio 44106 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15232 United States Details
GSK Investigational Site Greenville South Carolina 29605 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site Villejuif cedex 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field